Iris Loew-Friedrich, PhD
Chief Medical Officer & EVP, Development and Medical Practices, UCB
Prof. Dr. med. Iris Loew-Friedrich is Chief Medical Officer for UCB, a member of the company’s Executive Committee and Head of the Development & Medical Practices. She provides strategic global leadership for world-wide clinical development, medical affairs, regulatory affairs, real world evidence, patient safety/pharmacovigilance and external engagement. Iris started her service for patients in the pharmaceutical industry in 1992 with a focus on clinical development in the areas of immunology, bone disease and neurology, delivering together with her teams several novel medicines to patients. She held various positions in Research and Development in different companies, always with a focus on global drug development. Since 2001, prior to joining UCB, Iris was the Global Head of Research and Development at Schwarz Pharma (acquired by UCB in 2006) and a member of their Executive Committee. Iris is a physician, board-certified in internal medicine, with a medical license from the University of Frankfurt where she also holds a visiting professorship at the Medical School. Iris is active in industry associations, a member of different supervisory boards, including the board of TransCelerate and PhRMA Foundation. She is passionate about making a difference to the lives of people living with severe diseases.